| 释义 |
pro·lyl 英p'rɒlɪl美p'rɒlɪl COCA³¹⁵¹¹¹⁺⁴
基本例句
n.脯氨酰¹⁰⁰
Method By the international literature, the structure-activity relationships of prolyl oligopeptidase inhibitors, natural active constituents, and clinical studies were summed up.
方法根据国外相关文献，对脯氨酰寡肽酶抑制剂的构效关系、天然活性成分以及临床试验情况进行整理和归纳。 cnki
Objective To review advances of the study on prolyl oligopeptidase inhibitors, including evaluation of their structure-activity relationships, natural active constituents, and their clinical studies.
目的综述脯氨酰寡肽酶抑制剂的构效关系、天然活性成分以及临床研究等方面的进展。 cnki
Tripeptide L- prolyl- L- leucyl- glycinamidePLG has important physiological and pharmacological functions, and can be used to treat Parkinson's disease.
脯氨酰- L-亮氨酰-甘氨酰胺三肽，具有重要的生理药理作用，可用于治疗帕金森病。 cnki |